Of the four accessory proteins expressed by human immunodeficiency virus type 1 (HIV-1), Vpr is the least well understood. In PLoS Pathogens, Koyanagi and colleagues use a humanized mouse model to demonstrate the important role of Vpr in accelerating HIV-1 replication. Regulatory T cells (Treg cells) show 'preferential' infection with CCR5-tropic HIV-1, but not with CXCR4-tropic HIV-1, by virtue of their inherently high turnover rate and high expression of the entry coreceptor CCR5. Infection of Treg cells by HIV-1 results in their apoptosis and concomitant generalized activation of the immune system. Similarly, pharmacological depletion of Treg cells leads to the activation and proliferation of conventional T cells and a higher viral burden. Mutants with defective Vpr, however, show less infection and loss of Treg cells as well as a lower viral burden. The decrease in Treg cell numbers through the action of Vpr thus leads to impaired homeostatic regulation of conventional T cells and thereby increases the pool of activated cell targets and optimal HIV-1 replication.
Rights and permissions
About this article
Cite this article
Fehervari, Z. In vivo role for Vpr. Nat Immunol 15, 142 (2014). https://doi.org/10.1038/ni.2814
Published:
Issue Date:
DOI: https://doi.org/10.1038/ni.2814